Pro-Dex (PDEX) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Pro-Dex (PDEX) has outperformed Sanara MedTech (SMTI) over the past year, gaining 80.3% versus a gain of 10.9%. Over five years, PDEX leads with a +143.1% price change compared with +6.3% for SMTI. Sanara MedTech is the larger company by market cap ($322.2 million vs $202.0 million), about 1.6 times the size.
On valuation, Pro-Dex trades at a lower forward P/E (18.6x vs 64.9x for Sanara MedTech).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PDEX | SMTI |
|---|---|---|
| Share price | $62.49 | $35.07 |
| Market cap | $202.04M | $322.22M |
| 1-day change | +0.45% | +0.06% |
| YTD return | +62.40% | +50.19% |
| 1-year return | +80.35% | +10.95% |
| 5-year return | +143.06% | +6.34% |
| P/E ratio (TTM) | 15.20 | — |
| Forward P/E | 18.60 | 64.94 |
| EPS (TTM) | $4.11 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $77.00 | $35.34 |
| 52-week low | $23.47 | $16.05 |
| Distance from 52-week high | -18.84% | -0.76% |
| Analyst consensus | none | none |
| Avg. price target upside | +18.42% | -0.20% |
| Average volume | 79.80K | 280.40K |
| Shares outstanding | 3.23M | 9.19M |
| Employees | 201 | 108 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed SMTI by 69.4 percentage points over the past year.
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Health Care · Medical/Dental Instruments · 201 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
PDEX vs SMTI FAQ
Which is bigger, Pro-Dex or Sanara MedTech?
Sanara MedTech (SMTI) is larger, with a market capitalization of $322.22M compared with $202.04M for Pro-Dex (PDEX).
Which stock has performed better over the past year, PDEX or SMTI?
PDEX returned +80.35% over the past 12 months, compared with +10.95% for SMTI (price return, excluding dividends). Past performance does not predict future results.
Are Pro-Dex and Sanara MedTech in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Pro-Dex and Industrial Specialties for Sanara MedTech.